Save your place

Sign in to WhoBought

Please try again later.

Joel Greenblatt's AngioDynamics, Inc. (ANGO) position

Not anymore: Joel Greenblatt fully exited ANGO in Q3 2021. The position peaked at an amount we cannot price in Q2 2021.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
11K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

ANGO price vs Greenblatt's position

Dates
$13.5$14$14.5← Earlier —1 purchase
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q3 2021 Exited −11K −100.0% 0 Nov 15, 2021
Q2 2021 New +11K 11K Aug 16, 2021
Data through Q3 2021 · filed Nov 15, 2021
2 grouped rows from 2 quarters

More Greenblatt positions

Common questions

Does Joel Greenblatt own ANGO?

Not currently. Joel Greenblatt fully exited ANGO in Q3 2021, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Joel Greenblatt buy ANGO?

Joel Greenblatt first disclosed a ANGO position in Q2 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Joel Greenblatt sell ANGO?

Yes. Joel Greenblatt reduced and then fully exited ANGO by Q3 2021; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ANGO does Joel Greenblatt own?

None as of the latest filing: Joel Greenblatt has exited ANGO. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Joel Greenblatt pay for ANGO?

Joel Greenblatt began building the ANGO position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.